[1]宣恒报,成玉春,杨士军.医院感染的耐药菌分布特点与药物应用[J].医学信息,2019,32(22):114-116.[doi:10.3969/j.issn.1006-1959.2019.22.037]
　XUAN Heng-bao,CHENG Yu-chun,YANG Shi-jun.Distribution Characteristics and Drug Application of Drug-resistant Bacteria in Nosocomial Infection[J].Journal of Medical Information,2019,32(22):114-116.[doi:10.3969/j.issn.1006-1959.2019.22.037]
点击复制

医院感染的耐药菌分布特点与药物应用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年22期
页码:
114-116
栏目:
调查分析
出版日期:
2019-11-15

文章信息/Info

Title:
Distribution Characteristics and Drug Application of Drug-resistant Bacteria in Nosocomial Infection
文章编号:
1006-1959（2019）22-0114-03
作者:
宣恒报1; 成玉春1; 杨士军2
（南京医科大学附属淮安第一医院感染管理处1，检验科2，江苏 淮安 223300）
Author(s):
XUAN Heng-bao1; CHENG Yu-chun1; YANG Shi-jun2
(Infection Management Division1,Department of Laboratory2,Huai'an First Hospital, Nanjing Medical University,Huai'an 223300,Jiangsu,China)
关键词:
医院感染; 耐药菌; 抗生素; 合理用药
Keywords:
Nosocomial infection; Drug-resistant bacteria; Antibiotics; Rational use of drugs
分类号:
R446.5
DOI:
10.3969/j.issn.1006-1959.2019.22.037
文献标志码:
A
摘要:
目的 分析我院医院感染的耐药菌分布特点以及抗生素的应用情况。方法 选择2017年7月~2018年7月我院住院治疗的多重耐药菌感染者的生物标本进行细菌检测和药敏试验，并对结果进行分析。结果 检出多重耐药菌的为962株，检出率为14.70%（962/6542）；多重耐药菌株感染的发生率为21.74%（962/4425）；其中有478株（49.69%）为产超广谱β-内酰胺酶（ESBLs）大肠埃希菌；科室分布主要以普外科（186株，19.33%）最高；大肠埃希菌和肺炎克雷伯菌对于头孢西丁、头孢哌酮-舒巴坦、美罗培南、亚胺培南、哌拉西林-他唑巴坦和阿米卡星的耐药率较低；金黄色葡萄球菌对于替考拉林、阿米卡星、庆大霉素、万古霉素和利奈唑胺的耐药率均为0，对于左氧氟沙星和莫西沙星的耐药率较低。结论 细菌耐药的形势严峻，临床应用时要首选敏感度较高的抗生素，以防细菌耐药进一步发生。医院要严格加强防控举措，切实避免医院感染的发生。
Abstract:
Objective To analyze the distribution characteristics of drug-resistant bacteria in hospital infections in our hospital and the application of antibiotics. Methods The biological samples of multi-drug resistant patients hospitalized in our hospital from July 2017 to July 2018 were selected for bacterial detection and drug susceptibility test, and the results were analyzed. Results The number of multi-drug resistant strains detected was 962, the detection rate was 14.70% (962/6542); the incidence of multi-drug resistant strain infection was 21.74% (962/4425); among them, 478 (49.69%) were production of extended-spectrum β-lactamase (ESBLs) Escherichia coli; departmental distribution is mainly highest in general surgery (186 strains, 19.33%); Escherichia coli and Klebsiella pneumoniae for cefoxitin and cefoperazone-the resistance rates of sulbactam, meropenem, imipenem, piperacillin-tazobactam and amikacin are lower; Staphylococcus aureus for teicoplanin, amikacin, Qingda the resistance rates of mycin, vancomycin and linezolid were all 0, and the resistance rates to levofloxacin and moxifloxacin were lower. Conclusion The situation of bacterial resistance is severe, and antibiotics with higher sensitivity should be preferred for clinical application to prevent further bacterial resistance. The hospital must strictly strengthen prevention and control measures to avoid hospital infections.

参考文献/References:

[1]Humphreys G,Fleck F.United Nations meeting on antimicrobial resistance[J].Bull World Health Organ,2016,94(9):638-639. [2]Olga Jonas,World Bank Group Team.Drug-resistant infections:A threat to our economic future[M].Washington,D.C.,World Bank Group,2017:172. [3]欧阳育琪,林应标,黄红卫,等.多药耐药性感染的临床分析和耐药性监测[J].实用预防医学,2010,17(3):453-455. [4]黄勋,邓子德,倪语星,等.多重耐药菌医院感染预防与控制中国专家共识[J].中国感染控制杂志,2015,14(1):1-9. [5]尚红,王毓三,申子瑜.全国临床检验操作规程[M].第4版.北京:人民出版社,2014:574-773. [6]李春辉,吴安华.MDR、XDR、PDR多重耐药菌暂行标准定义-国际专家建议[J].中国感染控制杂志,2014,13(1):62-64. [7]高志玲,王静,李洋,等.2009-2011年医院感染相关危险因素分析[J].中国老年学杂志,2011,31(14):2780-2781． [8]耿建利,高若辉,宋宇,等.超广谱β-内酰胺酶的临床研究进展[J].医学检验与临床,2016,27(2):71-74. [9]Granzer H,Hagen RM,Warnke P,et al.Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii complex isolates form patients that were injured during the eastern Ukrainian conflict[J].Eur J Microbiol Immunol,2016,6(2):109-117. [10]侯盼飞,王欣,李秀玲,等.耐碳氢霉烯类鲍曼不动杆菌耐药机制研究[J].中华医院感染学杂志,2016,26(23):5292-5304.

相似文献/References:

[1]王雪梅,区 清.某二级医院医院感染现患率调查分析与对策[J].医学信息,2018,31(05):120.[doi:10.3969/j.issn.1006-1959.2018.05.042]
　WANG Xue-mei,QU Qing.Investigation and Analysis of Nosocomial Infection Rate in a Level-II Hospital and its Countermeasures[J].Journal of Medical Information,2018,31(22):120.[doi:10.3969/j.issn.1006-1959.2018.05.042]
[2]周 刚.右美托咪定改善全麻苏醒期患者血液动力学及 医院感染的疗效观察[J].医学信息,2018,31(12):128.[doi:10.3969/j.issn.1006-1959.2018.12.039]
　ZHOU Gang.Effect of Dexmedetomidine on Improving Hemodynamics and Nosocomial Infection in Patients with General Anesthesia[J].Journal of Medical Information,2018,31(22):128.[doi:10.3969/j.issn.1006-1959.2018.12.039]
[3]章 琦,郑雪梅,李宝珍,等.医务人员医院感染防控知信行现状及其培训需求调查分析[J].医学信息,2022,35(13):168.[doi:10.3969/j.issn.1006-1959.2022.13.042]
　ZHANG Qi,ZHENG Xue-mei,LI Bao-zhen,et al.Investigation and Analysis on KAP Status and Training Needs of Hospital Infection Prevention and Control Among Medical Staff[J].Journal of Medical Information,2022,35(22):168.[doi:10.3969/j.issn.1006-1959.2022.13.042]
[4]周 蓉.神经外科颅脑手术患者医院感染危险因素分析[J].医学信息,2019,32(07):104.[doi:10.3969/j.issn.1006-1959.2019.07.030]
　ZHOU Rong.Analysis of Risk Factors for Nosocomial Infection in Patients with Neurosurgical Brain Surgery[J].Journal of Medical Information,2019,32(22):104.[doi:10.3969/j.issn.1006-1959.2019.07.030]
[5]刘文军,张东湖,黄 锋,等.基于CDR的医院感染闭环管理应用[J].医学信息,2019,32(08):17.[doi:10.3969/j.issn.1006-1959.2019.08.005]
　LIU Wen-jun,ZHANG Dong-hu,HUANG Feng,et al.CDR-based Hospital Infection Closed-loop Management Application[J].Journal of Medical Information,2019,32(22):17.[doi:10.3969/j.issn.1006-1959.2019.08.005]
[6]顾万娟,李 亮,张 振,等.多重耐药菌的临床分布与耐药性分析[J].医学信息,2019,32(15):116.[doi:10.3969/j.issn.1006-1959.2019.15.038]
　GU Wan-juan,LI Liang,ZHANG Zhen,et al.Analysis of Clinical Distribution and Drug Resistance of Multi-drug Resistant Bacteria[J].Journal of Medical Information,2019,32(22):116.[doi:10.3969/j.issn.1006-1959.2019.15.038]
[7]吴毅萍,余 虹,沈菊艳.精细护理路径管理在消化内镜室医院感染控制中的应用效果[J].医学信息,2022,35(14):184.[doi:10.3969/j.issn.1006-1959.2022.14.048]
　WU Yi-ping,YU Hong,SHEN Ju-yan.Application Effect of Refined Nursing Pathway Management in Nosocomial Infection Control in Digestive Endoscopy Room[J].Journal of Medical Information,2022,35(22):184.[doi:10.3969/j.issn.1006-1959.2022.14.048]
[8]张 楠,白昊坤,赵 怀,等.某综合医院住院患者医院感染现患率调查[J].医学信息,2019,32(17):126.[doi:10.3969/j.issn.1006-1959.2019.17.041]
　ZHANG Nan,BAI Hao-kun,ZHAO Huai,et al.Investigation on the Prevalence of Nosocomial Infection in Hospitalized Patients in A General Hospital[J].Journal of Medical Information,2019,32(22):126.[doi:10.3969/j.issn.1006-1959.2019.17.041]
[9]杨 萍,袁华兵.三级综合医院多重耐药菌特点及直接经济负担分析[J].医学信息,2022,35(16):132.[doi:10.3969/j.issn.1006-1959.2022.16.033]
　YANG Ping,YUAN Hua-bing.Analysis of Characteristics and Direct Economic Burden of Multi-drug Resistant Organisms in Tertiary General Hospitals[J].Journal of Medical Information,2022,35(22):132.[doi:10.3969/j.issn.1006-1959.2022.16.033]
[10]王蓉芬,莫明露,陶 媛,等.2016~2018年某院ICU 医院感染目标性监测及干预[J].医学信息,2019,32(23):96.[doi:10.3969/j.issn.1006-1959.2019.23.026]
　WANG Rong-fen,MO Ming-lu,TAO Yuan,et al.Target Surveillance and Intervention of Nosocomial Infection in ICU from 2016 to 2018[J].Journal of Medical Information,2019,32(22):96.[doi:10.3969/j.issn.1006-1959.2019.23.026]

更新日期/Last Update: 2019-11-15